{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:37:46Z","timestamp":1694637466254},"reference-count":25,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.019","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T11:18:10Z","timestamp":1253099890000},"page":"6809-6813","source":"Crossref","is-referenced-by-count":4,"title":["Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis"],"prefix":"10.1016","volume":"27","author":[{"given":"Paul B.","family":"Keiser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori B.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Biggs-Cicatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendell D.","family":"Zollinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.09.019_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/qjmed\/hcg129","article-title":"Fibrinogen: biochemistry, epidemiology and determinants","volume":"96","author":"Kamath","year":"2003","journal-title":"QJM"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.09.019_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1538-7836.2003.00145.x","article-title":"Accuracy of D-dimer\/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study","volume":"1","author":"Kucher","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"October (14)","key":"10.1016\/j.vaccine.2009.09.019_bib3","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"issue":"May (18)","key":"10.1016\/j.vaccine.2009.09.019_bib4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.09.019_bib5","unstructured":"Baylor NW, moderator. Proceedings of a public workshop: adjuvants and adjuvanted preventive and therapeutic vaccines for infectious disease indications; 2009. Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/NewsEvents\/WorkshopsMeetingsConferences\/ucm095698.htm."},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.019_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0264-410X(93)90376-9","article-title":"Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant","volume":"11","author":"Keitel","year":"1993","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.019_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/07853890701390111","article-title":"Residual adverse changes in arterial endothelial function and LDL oxidation after a mild systemic inflammation induced by influenza vaccination","volume":"39","author":"Liuba","year":"2007","journal-title":"Ann Med"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2009.09.019_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1537-1891(02)00297-5","article-title":"Yellow fever vaccination as a model to study the response to stimulation of the inflammation system","volume":"39","author":"van der Beek","year":"2002","journal-title":"Vascul Pharmacol"},{"issue":"July (5)","key":"10.1016\/j.vaccine.2009.09.019_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.mbc.0000114444.59147.0a","article-title":"Interindividual variation in the response by fibrinogen, C-reactive protein and interleukin-6 to yellow fever vaccination","volume":"15","author":"Verschuur","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2009.09.019_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/cs0890389","article-title":"Whole-body protein turnover and hepatic protein synthesis are increased by vaccination in man","volume":"89","author":"Cayol","year":"1995","journal-title":"Clin Sci (Lond)"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2009.09.019_bib11","first-page":"822","article-title":"The effect of acute-phase proteins on inflammation edema due to vaccination","volume":"133","author":"van Gool","year":"1989","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2009.09.019_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF00915812","article-title":"Alpha 2-macroglobulin and fibrinogen modulate inflammatory edema in man","volume":"14","author":"van Gool","year":"1990","journal-title":"Inflammation"},{"issue":"June (Suppl 2)","key":"10.1016\/j.vaccine.2009.09.019_bib13","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.019_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2009.09.019_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(78)90260-9","article-title":"A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria","volume":"85","author":"Karkhanis","year":"1978","journal-title":"Anal Biochem"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.09.019_bib16","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.09.019_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/HAB-2008-173-401","article-title":"Fibrinogen binds IgG antibody and enhances IgG-mediated phagocytosis","volume":"17","author":"Boehm","year":"2008","journal-title":"Hum Antibodies"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2009.09.019_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/hy1101.099478","article-title":"Genes encoding fibrinogen and cardiovascular risk","volume":"38","author":"Iacoviello","year":"2001","journal-title":"Hypertension"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.09.019_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0037-1615704","article-title":"Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections","volume":"85","author":"Horan","year":"2001","journal-title":"Thromb Haemost"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2009.09.019_bib20","first-page":"307","article-title":"Seasonal variations of selected cardiovascular risk factors","volume":"10","author":"Kelly","year":"2005","journal-title":"Altern Med Rev"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.09.019_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/infdis\/169.4.807","article-title":"MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon","volume":"169","author":"Roers","year":"1994","journal-title":"J Infect Dis"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.09.019_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00392-003-0983-7","article-title":"Myocardial infarction after influenza vaccination","volume":"92","author":"Ritter","year":"2003","journal-title":"Z Kardiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.09.019_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/oxfordjournals.aje.a113063","article-title":"A study of excess mortality during influenza epidemics in the United States, 1968\u20131976","volume":"113","author":"Alling","year":"1981","journal-title":"Am J Epidemiol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2009.09.019_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0002-9149(84)90016-X","article-title":"Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients","volume":"53","author":"Spodick","year":"1984","journal-title":"Am J Cardiol"},{"issue":"April (6630)","key":"10.1016\/j.vaccine.2009.09.019_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bmj.296.6630.1156","article-title":"Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients","volume":"296","author":"Syrjanen","year":"1988","journal-title":"Br Med J (Clin Res Ed)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901336X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0901336X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T20:31:21Z","timestamp":1633897881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0901336X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":25,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X0901336X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}